During this study we examined the activity of cefepime/zidebactam (WCK 5222) versus consecutive reference laboratory submissions of Gram-unfavorable germs, taken being a sample of trouble strains circulating in britain. The real outcomes of the new cefepime combos will probable only be recognized when analyzed towards critical MDR infections in properly-done https://fionaz111lwh3.idblogz.com/profile